Neurology
When Dementia Takes Speech, Trials Must Catch Up
CervoMed has completed enrolment in a Phase IIa study of neflamapimod in nonfluent/agrammatic primary progressive aphasia. The milestone is small, but the unmet need is not.
Child Mental Health Access Still Depends on the Facility
Huntington’s Gets Another Chance at Proof
Duchenne Evidence Moves Into the Muscle
Migraine Prevention Gets a Wider Door
Stroke Rehab Cannot Stop at Survival
Alzheimer’s Trials Are Finally Blood-Gated
MS Regulators Are No Longer Reading the Same Risk
Europe Opens the SMA Gene-Therapy Door Wider
ALS Needs Proof, Not Just Another Biomarker
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.